May 14th - Penny Stock News Brief
Applied DNA Sciences ($APDN) is set to announce earnings on May 15th with an investor call following on June 3rd. The company’s annual stock holder meeting is scheduled for May 22nd and includes the requisite warrant conversion and executive incentive plans.
“the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024 (the “Warrant Exercise Proposal”);”Here is the relevant offering document.
“Each Series C Warrant will have an exercise price of $0.32 per share of common stock, will become exercisable upon the first trading day following the Company’s notice to warrantholders of Warrant Stockholder Approval (the “Stockholder Approval Date”), and will expire on the five-year anniversary of the Stockholder Approval Date. Each Series D Warrant will have an exercise price of $0.32 per share of common stock, will become exercisable upon the Stockholder Approval Date, and will expire on the eighteen-month anniversary of the Stockholder Approval Date.”
RBC Capital Markets Conference Updates
Verve Therapeutics ($VERV) presented. Here is the replay.
Beam Therapeutics ($BEAM) presented. Here is the replay.
European Hematology Assoc. (EHA) Congress Updates
Kura Oncology ($KURA) announced they will were selected for an oral presentation Thursday, June 12th.
Editas Medicine ($EDIT) is presenting a poster.
Terns Pharmaceutical ($TERN) was selected for an oral presentation.
30th European Hematology Assoc. Congress Updates
Nurix Therapeutics ($NRIX) is presenting a poster.
Patent Updates
Surrozen ($SRZN) announced a novel patent award.
FDA Updates
Cingulate announced an update regarding its upcoming NDA submission which is scheduled for this Summer.
Today’s Movers
Incannex Healthcare ($IXHL) is up (as of writing) 913%. Was on model and below the channel yesterday.
Klotho Neurosciences ($KLTO) is in the expected volatility window and tripped ∆Liquidity (purple line on volume) in April and is up 193%. This was showing consolidation trading prior to today’s move.
Caravelle International ($HTCO) is down 63% after a more than 100% move recently, again this stock is in the expected volatility window.
As always, if you think there are spelling errors update your dictionary to the latest version. Happy speculation!
— AJ
We can be found on Twitter.
Or in Chat.
Our charts are updated everyday as new data becomes available and are available via subscription. This is because the costs of doing this analysis across 15,000 securities is not cheap. Compute is not cheap. Neither is the effort required to find these plays before they move. But, it can be done by one person, alone. If you do nothing but read. Every day. So why not use our code instead?
DISCLAIMER: DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Our website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Past performance is not indicative of future results. The material contained on this page is intended for informational purposes only. GravityAnalytica.com is wholly-owned by Gravity Analytica, LLC. Our website is not an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content of our website and/or newsletter is not provided to any individual with a view toward their individual circumstances. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on our website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. We reserve the right to buy or sell shares of any company mentioned on our website or in our newsletter at any time. We encourage you to invest carefully and read investment information available at the websites of the SEC at
and FINRA at
The company or individuals affiliated may hold positions or may enter into, or exit, positions on any equities at any time. This website and materials found on this website, or in any communication, are meant for individuals of eighteen (18) years of age or older and are not suitable for younger audiences. Materials and information provided on this website and in any communications with or from Gravity Analytica LLC, it's employees or affiliates, are for personal education use by subscribers and may be not be used in any regard in competition with this website or any other product or service offered by Gravity Analytica LLC. Past results do not predict future returns. IF YOU DO NOT AGREE WITH THE TERMS OF THIS DISCLAIMER, PLEASE EXIT THIS SITE IMMEDIATELY. PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.